PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 67 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -66.7% | 13,715 | -28.1% | 0.00% | -80.0% |
| Q4 2020 | $48,000 | -78.3% | 19,088 | -70.5% | 0.01% | -70.6% |
| Q3 2019 | $221,000 | -37.2% | 64,683 | +25.8% | 0.02% | -10.5% |
| Q1 2018 | $352,000 | +60.7% | 51,431 | +77.4% | 0.02% | +58.3% |
| Q4 2017 | $219,000 | +29.6% | 28,986 | -1.0% | 0.01% | +50.0% |
| Q3 2017 | $169,000 | – | 29,293 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
| BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
| Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
| Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
| EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
| Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
| EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
| Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |